Invest in 5,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. more
Time Frame | DXCM | Sector | S&P500 |
---|---|---|---|
1-Week Return | 3.05% | 0.69% | 0.24% |
1-Month Return | -7.35% | -0.95% | -1.41% |
3-Month Return | 3.79% | -1.44% | 3.85% |
6-Month Return | 36.7% | 11.14% | 18.3% |
1-Year Return | 7.88% | 7.82% | 25.83% |
3-Year Return | 45.13% | 20.25% | 27.74% |
5-Year Return | 324.35% | 70.1% | 89.77% |
10-Year Return | 1600.33% | 188.35% | 229.77% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 1.48B | 1.93B | 2.45B | 2.91B | 3.62B | [{"date":"2019-12-31","value":40.75,"profit":true},{"date":"2020-12-31","value":53.19,"profit":true},{"date":"2021-12-31","value":67.6,"profit":true},{"date":"2022-12-31","value":80.33,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 544.50M | 646.60M | 768.00M | 1.03B | 1.33B | [{"date":"2019-12-31","value":40.84,"profit":true},{"date":"2020-12-31","value":48.49,"profit":true},{"date":"2021-12-31","value":57.6,"profit":true},{"date":"2022-12-31","value":77,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 931.50M | 1.28B | 1.68B | 1.88B | 2.29B | [{"date":"2019-12-31","value":40.7,"profit":true},{"date":"2020-12-31","value":55.93,"profit":true},{"date":"2021-12-31","value":73.42,"profit":true},{"date":"2022-12-31","value":82.27,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 63.11% | 66.44% | 68.63% | 64.72% | 63.19% | [{"date":"2019-12-31","value":91.95,"profit":true},{"date":"2020-12-31","value":96.8,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.29,"profit":true},{"date":"2023-12-31","value":92.07,"profit":true}] |
Operating Expenses | 789.20M | 980.60M | 1.41B | 1.49B | 1.69B | [{"date":"2019-12-31","value":46.67,"profit":true},{"date":"2020-12-31","value":57.98,"profit":true},{"date":"2021-12-31","value":83.65,"profit":true},{"date":"2022-12-31","value":88.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 142.30M | 299.50M | 175.40M | 391.20M | 597.70M | [{"date":"2019-12-31","value":23.81,"profit":true},{"date":"2020-12-31","value":50.11,"profit":true},{"date":"2021-12-31","value":29.35,"profit":true},{"date":"2022-12-31","value":65.45,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (72.00M) | (143.10M) | (101.80M) | (19.00M) | 112.70M | [{"date":"2019-12-31","value":-63.89,"profit":false},{"date":"2020-12-31","value":-126.97,"profit":false},{"date":"2021-12-31","value":-90.33,"profit":false},{"date":"2022-12-31","value":-16.86,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | 104.20M | 225.00M | 173.90M | 390.80M | 710.40M | [{"date":"2019-12-31","value":14.67,"profit":true},{"date":"2020-12-31","value":31.67,"profit":true},{"date":"2021-12-31","value":24.48,"profit":true},{"date":"2022-12-31","value":55.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income Taxes | 3.10M | (268.60M) | 19.20M | 49.60M | 168.90M | [{"date":"2019-12-31","value":1.84,"profit":true},{"date":"2020-12-31","value":-159.03,"profit":false},{"date":"2021-12-31","value":11.37,"profit":true},{"date":"2022-12-31","value":29.37,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | 101.10M | 493.60M | 154.70M | 341.20M | 541.50M | [{"date":"2019-12-31","value":18.67,"profit":true},{"date":"2020-12-31","value":91.15,"profit":true},{"date":"2021-12-31","value":28.57,"profit":true},{"date":"2022-12-31","value":63.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | 101.10M | 493.60M | 154.70M | 341.20M | 541.50M | [{"date":"2019-12-31","value":18.67,"profit":true},{"date":"2020-12-31","value":91.15,"profit":true},{"date":"2021-12-31","value":28.57,"profit":true},{"date":"2022-12-31","value":63.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 101.10M | 493.60M | 154.70M | 341.20M | 541.50M | [{"date":"2019-12-31","value":18.67,"profit":true},{"date":"2020-12-31","value":91.15,"profit":true},{"date":"2021-12-31","value":28.57,"profit":true},{"date":"2022-12-31","value":63.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 0.46 | 0.78 | 0.66 | 0.87 | 1.51 | [{"date":"2019-12-31","value":30.46,"profit":true},{"date":"2020-12-31","value":51.66,"profit":true},{"date":"2021-12-31","value":43.71,"profit":true},{"date":"2022-12-31","value":57.62,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
DXCM | |
---|---|
Cash Ratio | 1.82 |
Current Ratio | 2.90 |
Quick Ratio | 2.53 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
DXCM | |
---|---|
ROA (LTM) | 6.79% |
ROE (LTM) | 28.54% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
DXCM | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.65 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.35 |
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. | 2.89 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
DXCM | |
---|---|
Trailing PE | 83.36 |
Forward PE | 77.52 |
P/S (TTM) | 14.49 |
P/B | 25.38 |
Price/FCF | 335 |
EV/R | 14.46 |
EV/Ebitda | 57.12 |
PEG | 0.67 |
By now, you’ve heard of the Internet of Things (IoT) — or the network of physical devices, vehicles and other things embedded with sensors, software and network connectivity, which allows them to collect and share data . That includes smart thermostats, smartwatches, vehicles and industrial machines to name a few. There have even been calls for “smart cities” based on IoT. All of which is a catalyst for some of the top IoT stocks. Plus, according to IBM (NYSE: IBM ), “The number of IoT devices is expected to continue to grow rapidly, with estimates suggesting that there will be tens of billion IoT devices in use over the next few years. This growth will be driven by increased adoption across industries, as well as the development of new use cases and applications.” “Artificial intelligence and machine learning are becoming increasingly important for IoT, as they can be used to analyze vast amounts of data that is generated by IoT devices and extract meaningful insights. This can help businesses make more informed decisions and optimize their operations,” they added.
IoT’s benefit lies in its capacity to enhance convenience, efficiency and safety across various domains. IoT enables real-time monitoring and data exchange by connecting everyday objects to the internet, empowering users with valuable insights and automated responses. Whether receiving timely alerts about low gas levels during travel or optimizing industrial processes for cost savings, IoT’s impact spans from personal convenience to transformative business applications. This promises a future where interconnected devices streamline tasks and improve decision-making. IoT stocks have immense future potential in our ever-growing digital society; getting in now spells high profitability for your portfolio. Another reason you should invest in IoT is that the economy is strong, meaning technological innovation will continue, so investing in tech is a smart choice. These IoT stocks are all solid buys, currently flying under Wall Street’s radar, with untapped profit and growth potential. This is your chance to get in at a discount before the Wall Street whales.
The healthcare scene is home to some pretty defensive companies that aren’t exactly shying away from medical innovation. With the following Strong-…
DXCM earnings call for the period ending March 31, 2024.
DexCom (NASDAQ: DXCM ) just reported results for the first quarter of 2024. DexCom reported earnings per share of 32 cents. This was above the analyst estimate for EPS of 27 cents. The company reported revenue of $921.00 million. This was 1.29% better than the analyst estimate for revenue of $909.24 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million.
DexCom Inc (DXCM) share price today is $129.65
Yes, Indians can buy shares of DexCom Inc (DXCM) on Vested. To buy DexCom Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in DXCM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of DexCom Inc (DXCM) via the Vested app. You can start investing in DexCom Inc (DXCM) with a minimum investment of $1.
You can invest in shares of DexCom Inc (DXCM) via Vested in three simple steps:
The 52-week high price of DexCom Inc (DXCM) is $142. The 52-week low price of DexCom Inc (DXCM) is $74.75.
The price-to-earnings (P/E) ratio of DexCom Inc (DXCM) is 86.43
The price-to-book (P/B) ratio of DexCom Inc (DXCM) is 25.38
The dividend yield of DexCom Inc (DXCM) is 0.00%
The market capitalization of DexCom Inc (DXCM) is $51.56B
The stock symbol (or ticker) of DexCom Inc is DXCM